Independent Medical Education Request for Proposals - KRAS G12C+ NSCLC
Roche's grant supports medical education projects advancing knowledge and care for KRAS G12C-positive non-small cell lung cancer through evidence-based, practice-focused initiatives.
Funder: Roche
Due Dates: September 16, 2026
Funding Amounts: Up to $225,000 per project; single-year support typical
Summary: Supports independent medical education projects to advance knowledge and care for KRAS G12C-positive non-small cell lung cancer (NSCLC).
Key Information: Only U.S.-based, accredited CME/CE providers with a registered gFRS account are eligible.
Description
This opportunity supports independent, certified medical education initiatives focused on KRAS G12C-positive non-small cell lung cancer (NSCLC). Roche (via Genentech) seeks proposals that address critical educational gaps, promote best practices, and enhance the competence and performance of healthcare professionals—particularly community oncologists and multidisciplinary cancer teams. Projects should aim to improve diagnosis, treatment, and patient outcomes in this genomically distinct NSCLC subgroup, leveraging the latest evidence and clinical advancements.
